Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

Action Potentials

Action Potentials

Action Potential

Action Potential

Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...

Action Potential

Action Potential

Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Neurons: The Axon

Neurons: The Axon

Axons are long, cytoplasmic processes of nerve cells capable of propagating electrical impulses known as action potentials. The cytoplasm or axoplasm of an axon contains neurofibrils, neurotubules, small vesicles, lysosomes, mitochondria, and various enzymes, all encased within the axolemma, the plasma membrane of the axon.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin.

Annals of neurology·2026

Same author

Rare but Relevant? Assessing Variants in Dystonia-Linked Genes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025

Same author

A Mild Ataxia-Dominant Phenotype of Phosphomannomutase 2-Congenital Disorder of Glycosylation in a Tunisian Family: Broadening the Geographical Scope.

Journal of movement disorders·2025

Same author

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson's Disease.

medRxiv : the preprint server for health sciences·2025

Same author

Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase.

International journal of molecular sciences·2025

Same author

The Evolution of Genetic Variability at the <i>LRRK2</i> Locus.

Genes·2024

Search research articles

Related Experiment Video

Updated: May 9, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Giant axonal neuropathy.

Fayçal Hentati¹, Emna Hentati, Rim Amouri

¹Department of Neurology, Institut National Mongi Ben Hamida de Neurologie, Medical Faculty of Tunis, Université El Manar, Tunis, Tunisia.

Handbook of Clinical Neurology

|August 13, 2013

Summary

Giant axonal neuropathy (GAN) is a rare genetic disease causing severe nerve damage. Mutations in the GAN gene disrupt protein degradation, offering insights into other neurodegenerative disorders.

Keywords:

Parkinson disease amyotrophic lateral sclerosis giant axonal neuropathy giant axons gigaxonin gigaxonin mutations hereditary neuropathy iminodipropionitril ubiquitin

More Related Videos

An Ex Vivo Laser-induced Spinal Cord Injury Model to Assess Mechanisms of Axonal Degeneration in Real-time

An Ex Vivo Laser-induced Spinal Cord Injury Model to Assess Mechanisms of Axonal Degeneration in Real-time

Published on: November 25, 2014

Related Experiment Videos

Last Updated: May 9, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

An Ex Vivo Laser-induced Spinal Cord Injury Model to Assess Mechanisms of Axonal Degeneration in Real-time

An Ex Vivo Laser-induced Spinal Cord Injury Model to Assess Mechanisms of Axonal Degeneration in Real-time

Published on: November 25, 2014

Area of Science:

Genetics
Neuroscience
Molecular Biology

Background:

Giant axonal neuropathy (GAN) is a rare, inherited neurodegenerative disorder.
It affects both peripheral and central nervous systems, with onset in childhood.
Key features include progressive neuropathy, central nervous system signs, and characteristic giant axons.

Purpose of the Study:

To investigate the genetic basis of GAN.
To understand the molecular mechanisms underlying gigaxonin deficiency.
To explore GAN as a model for neurodegenerative diseases.

Main Methods:

Genetic analysis of the GAN gene.
Biopsy analysis to identify pathological features like giant axons and neurofilaments.
Molecular studies on gigaxonin function and protein degradation pathways.

Main Results:

Identified mutations in the GAN gene causing gigaxonin deficiency.
Demonstrated that gigaxonin deficiency impairs ubiquitin-mediated protein degradation.
Observed giant axons, neurofilament accumulation, and axonal loss in nerve biopsies.

Conclusions:

GAN is caused by mutations in the GAN gene, leading to gigaxonin deficiency.
This deficiency disrupts protein degradation, impacting neuronal health.
Studying GAN provides valuable insights into the ubiquitin proteasome system and neurofilament interactions, relevant to other neurodegenerative diseases like ALS and Parkinson's.